Different hierarchical reconfigurations in the brain by psilocybin and escitalopram for depression

Different hierarchical reconfigurations in the brain by psilocybin and escitalopram for depression

Effective interventions for neuropsychiatric disorders may work by rebalancing the brain’s functional hierarchical organization. Here we directly investigated the effects of two different serotonergic pharmacological interventions on functional brain hierarchy in major depressive disorder in a two-a...

Bibliografski detalji
Glavni autori:	Deco, G, Sanz Perl, Y, Johnson, S, Bourke, N, Carhart-Harris, RL, Kringelbach, ML
Format:	Journal article
Jezik:	English
Izdano:	Nature Research 2024

Slični predmeti

Brain dynamics predictive of response to psilocybin for treatment-resistant depression
od: Vohryzek, J, i dr.
Izdano: (2024)

Dynamical exploration of the repertoire of brain networks at rest is modulated by psilocybin
od: Lord, L-D, i dr.
Izdano: (2019)

Study protocol for “Psilocybin in patients with fibromyalgia: brain biomarkers of action”
od: Julia Bornemann, i dr.
Izdano: (2024-06-01)

Transient destabilization of whole brain dynamics induced by N,N-Dimethyltryptamine (DMT)
od: Piccinini, JI, i dr.
Izdano: (2025)

Whole-brain turbulent dynamics predict responsiveness to pharmacological treatment in major depressive disorder
od: Escrichs, A, i dr.
Izdano: (2024)

Turbulent dynamics and whole-brain modeling: toward new clinical applications for traumatic brain injury
od: Noelia Martínez-Molina, i dr.
Izdano: (2024-03-01)

Effects of escitalopram therapy on functional brain controllability in major depressive disorder
od: Fang, F, i dr.
Izdano: (2022)

Psychotherapy with Psilocybin for Depression: Systematic Review
od: Jonathan Joseph Dawood Hristova, i dr.
Izdano: (2023-03-01)

Escitalopram versus other antidepressive agents for depression.
od: Cipriani, A, i dr.
Izdano: (2009)

Connectome-harmonic decomposition of human brain activity reveals dynamical repertoire re-organization under LSD
od: Atasoy, S, i dr.
Izdano: (2017)

Scaling of whole-brain dynamics reproduced by high-order moments of turbulence indicators
od: Yonatan Sanz Perl, i dr.
Izdano: (2023-09-01)

Study protocol for “psilocybin as a treatment for anorexia nervosa: a pilot study”
od: Spriggs, MJ, i dr.
Izdano: (2021)

Psilocybin as a new way for depression treatment
od: Mateusz Maciej Pawlicki, i dr.
Izdano: (2024-05-01)

Unraveling the Potential of Isorhamnetin as an Adjuvant in Depression Treatment with Escitalopram
od: Omar Gammoh, i dr.
Izdano: (2023-09-01)

P.0353 Study protocol: psilocybin as a treatment for anorexia nervosa: a pilot study
od: Douglass, H, i dr.
Izdano: (2021)

Re-awakening the brain: Forcing transitions in disorders of consciousness by external in silico perturbation
od: Dagnino, PC, i dr.
Izdano: (2024)

THE EMERGENCE OF THE ARROW OF TIME IN WHOLE-BRAIN DYNAMICS
od: Sebastian Geli, i dr.
Izdano: (2023-10-01)

Risks of using psilocybin in treatment of treatment-resistant depression
od: Michał Orzechowski, i dr.
Izdano: (2025-03-01)

The development of psilocybin therapy for treatment-resistant depression: an update
od: Anya Borissova, i dr.
Izdano: (2024-02-01)

Psilocybin for Depression: From Credibility to Feasibility, What’s Missing?
od: Antonio Munafò, i dr.
Izdano: (2022-12-01)

Effects of psilocybin-assisted therapy on treatment-resistant depression
od: A. Fraga, i dr.
Izdano: (2021-04-01)

The therapeutic potential of psilocybin in depression resistant to psychotropic drugs
od: J. Ramírez González, i dr.
Izdano: (2023-03-01)

Systematic Review on the Mechanisms of Action of Psilocybin in the Treatment of Depression
od: M. C. Q. Lin, i dr.
Izdano: (2023-03-01)

Association of Psilocybin Use in Adolescents with Major Depressive Episode
od: K. Shah, i dr.
Izdano: (2022-06-01)

Escitalopram in patients with psoriasis
od: M. Artemieva, i dr.
Izdano: (2021-04-01)

The evolution of whole-brain turbulent dynamics during recovery from traumatic brain injury
od: Noelia Martínez-Molina, i dr.
Izdano: (2024-02-01)

Longitudinal experiences of Canadians receiving compassionate access to psilocybin-assisted psychotherapy
od: Sara de la Salle, i dr.
Izdano: (2024-07-01)

Use of escitalopram to prevent depression and cognitive impairments in the acute phase of stroke
od: Dina Rustemovna Khasanova, i dr.
Izdano: (2013-11-01)

Review of the brain areas activated in fMRI after escitalopram antidepressant treatment inpatients with major depressive disorder
od: Mao Yi, i dr.
Izdano: (2021-08-01)

Oxygen and the spark of human brain evolution: complex interactions of metabolism and cortical expansion across development and evolution
od: Luppi, AI, i dr.
Izdano: (2022)

Navigating Pubertal Goldilocks: The Optimal Pace for Hierarchical Brain Organization
od: Hanna Szakács, i dr.
Izdano: (2024-06-01)

Whole-brain multimodal neuroimaging model using serotonin receptor maps explains non-linear functional effects of LSD
od: Deco, G, i dr.
Izdano: (2018)

Unlocking the healing power of psilocybin: an overview of the role of psilocybin therapy in major depressive disorder, obsessive-compulsive disorder and substance use disorder
od: Sandra Szafoni, i dr.
Izdano: (2024-06-01)

Escitalopram-Induced Hyperprolactinemic Galactorrhea
od: Deepthi Yedla, i dr.
Izdano: (2022-10-01)

The Relationship Between Theta Power, Theta Asymmetry and the Effect of Escitalopram in the Treatment of Depression
od: Gao M, i dr.
Izdano: (2023-10-01)

Psilocybin: Psychotherapy or drug?
od: Goodwin, G
Izdano: (2016)

The Therapeutic Potential of Psilocybin
od: Henry Lowe, i dr.
Izdano: (2021-05-01)

Efficacy of psilocybin for treating symptoms of depression: systematic review and meta-analysis
od: Metaxa, A, i dr.
Izdano: (2024)

Co-use of MDMA with psilocybin/LSD may buffer against challenging experiences and enhance positive experiences
od: Richard J. Zeifman, i dr.
Izdano: (2023-08-01)

The ‘PSILAUT’ protocol: an experimental medicine study of autistic differences in the function of brain serotonin targets of psilocybin
od: Tobias P. Whelan, i dr.
Izdano: (2024-04-01)